317 related articles for article (PubMed ID: 22914471)
1. Ten-year relative survival for epithelial ovarian cancer.
Baldwin LA; Huang B; Miller RW; Tucker T; Goodrich ST; Podzielinski I; DeSimone CP; Ueland FR; van Nagell JR; Seamon LG
Obstet Gynecol; 2012 Sep; 120(3):612-8. PubMed ID: 22914471
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
3. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
5. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer.
Wright JD; Ananth CV; Tsui J; Glied SA; Burke WM; Lu YS; Neugut AI; Herzog TJ; Hershman DL
Cancer; 2014 Apr; 120(8):1246-54. PubMed ID: 24443159
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
[TBL] [Abstract][Full Text] [Related]
8. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.
Fuh KC; Shin JY; Kapp DS; Brooks RA; Ueda S; Urban RR; Chen LM; Chan JK
Gynecol Oncol; 2015 Mar; 136(3):491-7. PubMed ID: 25455734
[TBL] [Abstract][Full Text] [Related]
9. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands.
van Altena AM; Karim-Kos HE; de Vries E; Kruitwagen RF; Massuger LF; Kiemeney LA
Gynecol Oncol; 2012 Jun; 125(3):649-54. PubMed ID: 22370602
[TBL] [Abstract][Full Text] [Related]
10. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
[TBL] [Abstract][Full Text] [Related]
11. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
Son JH; Kong TW; Paek J; Song KH; Chang SJ; Ryu HS
Int J Gynaecol Obstet; 2017 Dec; 139(3):352-357. PubMed ID: 28857180
[TBL] [Abstract][Full Text] [Related]
13. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
[TBL] [Abstract][Full Text] [Related]
14. Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?
Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
Gynecol Oncol; 2017 Oct; 147(1):81-84. PubMed ID: 28716307
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
Wu M; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
[TBL] [Abstract][Full Text] [Related]
16. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
17. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
[TBL] [Abstract][Full Text] [Related]
18. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature.
Blake EA; Kodama M; Yunokawa M; Ross MS; Ueda Y; Grubbs BH; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():97-105. PubMed ID: 25668134
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of marital status on survival of women with epithelial ovarian cancer.
Mahdi H; Kumar S; Munkarah AR; Abdalamir M; Doherty M; Swensen R
Psychooncology; 2013 Jan; 22(1):83-8. PubMed ID: 21919121
[TBL] [Abstract][Full Text] [Related]
20. The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Pérez-Milán F; Ortiz-Quintana L
Surg Oncol; 2014 Mar; 23(1):40-4. PubMed ID: 24183480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
